- Home
- NBIX vs EBR Comparison
NBIX vs EBR Comparison
Compare NBIX & EBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- EBR
- Stock Information
- Founded
- NBIX 1992
- EBR 1962
- Country
- NBIX United States
- EBR Brazil
- Employees
- NBIX N/A
- EBR N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- EBR Electric Utilities: Central
- Sector
- NBIX Health Care
- EBR Utilities
- Exchange
- NBIX Nasdaq
- EBR Nasdaq
- Market Cap
- NBIX 13.1B
- EBR 13.9B
- IPO Year
- NBIX 1996
- EBR N/A
- Fundamental
- Price
- NBIX $135.45
- EBR $5.48
- Analyst Decision
- NBIX Buy
- EBR
- Analyst Count
- NBIX 23
- EBR 0
- Target Price
- NBIX $165.00
- EBR N/A
- AVG Volume (30 Days)
- NBIX 910.2K
- EBR 1.5M
- Earning Date
- NBIX 02-05-2025
- EBR 02-10-2025
- Dividend Yield
- NBIX N/A
- EBR 1.36%
- EPS Growth
- NBIX 97.40
- EBR 249.43
- EPS
- NBIX 3.73
- EBR 0.84
- Revenue
- NBIX $2,242,800,000.00
- EBR $6,993,057,205.00
- Revenue This Year
- NBIX $27.07
- EBR $9.43
- Revenue Next Year
- NBIX $16.60
- EBR $3.41
- P/E Ratio
- NBIX $36.12
- EBR $6.95
- Revenue Growth
- NBIX 25.72
- EBR 5.06
- 52 Week Low
- NBIX $110.95
- EBR $5.55
- 52 Week High
- NBIX $157.98
- EBR $9.11
- Technical
- Relative Strength Index (RSI)
- NBIX 68.12
- EBR 31.73
- Support Level
- NBIX $125.61
- EBR $5.87
- Resistance Level
- NBIX $130.48
- EBR $6.32
- Average True Range (ATR)
- NBIX 2.92
- EBR 0.16
- MACD
- NBIX 0.72
- EBR -0.01
- Stochastic Oscillator
- NBIX 69.33
- EBR 2.11
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.
About EBR Centrais Electricas Brasileiras S A (Each representing one Common Share)
Centrais Eletricas Brasileiras SA is engaged in the generation, transmission, and commercialization of electricity in Brazil. The company operates a portfolio of wind, thermal, hydro, and nuclear power plants located throughout the country. Its segments are Generation which consists of the generation of electric energy and the sale of energy to distribution companies and free consumers, and commercialization; Transmission which consists of the transmission of electric energy; and Administration activities mainly represent the Company's cash management, the management of the compulsory loan, and the management of business in SPEs, and others.